secwatch.observer — SEC 8-K summary
======================================

Issuer:     enVVeno Medical Corp (NVNO)
CIK:        0001661053
Form:       8-K
Filed at:   2021-08-12T23:59:59+00:00
Accession:  0001493152-21-019562
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hancock Jaffe enters $25M ATM equity offering with Ladenburg Thalmann
---------------------------------------------------------------------

- Up to $25M of common stock may be sold through Ladenburg Thalmann as agent.
- Ladenburg Thalmann will receive a 3% commission on gross proceeds.
- Agreement effective until August 12, 2023, or earlier termination.
- Sales may be made at market prices on Nasdaq Capital Market or in negotiated transactions.
- Company is not obligated to sell any shares under the agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661053/000149315221019562/0001493152-21-019562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661053/000149315221019562/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-019562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer